Novartis Blocks Sun’s Nilotinib Plans In India

 
• By Anju Ghangurde
  
3D illustration of rubber stamp with the text patented. IP law and intellectual property patent concept - Illustration
Novartis Defends Nilotinib Patent In India • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia